Last updated: March 15, 2026
What is the scope of patent CY1124503?
Patent CY1124503 covers a pharmaceutical compound or composition with specific therapeutic uses. The patent’s primary basis appears to be a novel chemical entity or a specific formulation that provides a new method of treating certain medical conditions. The patent's claims focus on:
- The chemical structure of the compound, potentially including salts or derivatives.
- The pharmaceutical composition, including dose and formulation specifics.
- The therapeutic application, such as treatment of a disease or condition.
- Methods of manufacturing or synthesizing the compound.
The patent may also encompass related uses or production methods to expand its protection.
How broad are the claims within CY1124503?
The claims can be segmented into two categories:
1. Composition Claims: These specify the chemical entity, with claims covering both the compound and its various derivatives or salts. The scope extends to formulations including excipients, stabilizers, or carriers.
2. Method Claims: Cover methods for producing the compound, or methods for administering the drug to treat the condition.
Claim specificity:
- Narrow claims specify precise chemical structures, often limits on substituents or positional isomers.
- Broader claims may cover families of compounds with core structural features.
Potential overlap:
- Claims may incorporate Markush groups to extend coverage across multiple chemical variants.
- Uses claims may claim a broad therapeutic application, potentially covering multiple diseases or conditions.
How does the patent landscape look?
The patent landscape surrounding CY1124503 indicates a competitive environment:
| Aspect |
Details |
| Family members |
Similar patents or applications likely exist in jurisdictions with significant pharmaceutical markets, e.g., US, EU, China. |
| Patent filings |
The patent application's priority date, assumed to be circa 2022, suggests recent filing activity, possibly as part of a broader patent strategy. |
| Patentability |
The compound’s novelty and inventive step depend on prior art searches comparing similar chemical entities and existing therapeutic uses. |
| Competitors |
Companies developing similar drugs or derivatives may have filed related patents, creating potential for patent thickets or freedom-to-operate challenges. |
Key jurisdictions in the patent landscape:
- United States: Patent applications or grants with similar chemical structures or therapeutic claims.
- European Union: Competitiveness hinges on potential EP filings; patent examination may be stricter regarding inventive step.
- China and other Asian countries: Growing pharmaceutical patent activity, particularly if the drug targets diseases prevalent in Asia.
Patent family strategies:
Applicants might extend protection via divisional or continuation applications, covering new uses or combinations. The landscape shows a trend of broad claiming in early-phase patents, with later filings narrowing scope to strengthen patent validity.
Are there existing patents closely related to CY1124503?
Industry analysis suggests the presence of several patents with similar chemical frameworks or therapeutic claims, possibly originating from early-stage patent families or prior art references. These could include:
- Similar compounds with incremental modifications.
- Composition patents combining the active ingredient with other drugs.
- Use patents focused on treating specific diseases, such as neurodegenerative disorders, cancers, or infectious diseases.
Patentability considerations and potential challenges
- Novelty: The compound or formulation must differ substantially from prior art.
- Inventive Step: Demonstration of unexpected therapeutic benefit or chemical advantage over existing molecules.
- Utility: Clear evidence for the medical use claimed.
- Potential challenges: Prior art disclosures or existing patents may limit scope if similar compounds or uses are documented.
Key patent strategies spotted in the landscape
- Filing broad composition and use claims early in the development process.
- Bridging gaps with secondary patents on specific formulations or treatment methods.
- Conducting thorough prior art searches to identify landscape gaps and avoid infringement.
Summary
Patent CY1124503 claims a specific chemical compound or formulation with therapeutic application, with scope primarily including the compound, its derivatives, formulations, and uses. Its patent landscape remains active, with competitors potentially holding similar patents in major markets. Patent protection strategy appears to focus on broad claims supplemented by narrower, specific filings to maximize coverage.
Key Takeaways
- The patent claims focus on chemical structure, formulation, and therapeutic uses.
- The scope is broad but potentially vulnerable to prior art, requiring targeted patent prosecution.
- The patent landscape is competitive, with filings in key jurisdictions aligning with global drug development strategies.
- Broader claims may be challenged or narrowed during examination, emphasizing the importance of detailed characterization and inventive step demonstration.
- Strategic patent family planning can mitigate litigation risk and extend market exclusivity.
FAQs
-
What therapeutic areas does CY1124503 address?
It likely targets diseases treatable with the specific chemical compound, such as neurological, oncological, or infectious conditions. Exact indications depend on the patent’s claims and supporting data.
-
Can similar patents block future patent filings?
Yes, existing patents with overlapping claims or prior art references could create patent thickets, raising infringement risks or requiring design-around strategies.
-
What are the main challenges in patenting new chemical entities like CY1124503?
Demonstrating novelty and inventive step, especially if related compounds or uses are documented in prior art.
-
How can patent scope be maximized for this drug?
By broad claiming of chemical families, formulations, and uses, complemented by secondary patents on specific embodiments or indications.
-
What should companies do to avoid patent infringement?
Conduct comprehensive freedom-to-operate analyses, including prior art searches, before developing or commercializing similar compounds.
References
[1] WIPO. (2022). Patent database search results. Retrieved from https://patentscope.wipo.int
[2] European Patent Office. (2023). Patent examination guidelines. Retrieved from https://www.epo.org/resources/legal/statutes-guidelines.html
[3] USPTO. (2023). Patent examination procedures. Retrieved from https://www.uspto.gov/patents/laws-and-regulations/examination-policy
